Prem Arokiaraj’s Post

As a passionate advocate for cutting-edge medical technology, I'm thrilled by the performance of RadiusXR, a game-changer in the field of visual field testing. 💡 Let's dive into the technical differentiators: 1️⃣ Precision Engineering: Unlike other virtual reality perimeters (VRPs) that repurpose consumer-grade gaming headsets, RadiusXR is meticulously designed and manufactured specifically for ophthalmology. This ensures optimal performance and reliability, giving clinicians the assurance they need in their diagnostic tools. 🔬 2️⃣ Unparalleled Accuracy: Our NOVA Clinical Trial has demonstrated a remarkable 0.94 correlation in mean deviation and statistical non-inferiority for glaucoma staging compared to traditional methods. This level of accuracy is a game-changer in diagnosing and managing ocular conditions, empowering clinicians with actionable insights to improve patient outcomes. 📊Read the peer-reviewed publication in the Journal of Translational Vision Science and Technology published by the Association for Research in Vision and Ophthalmology (ARVO). 3️⃣ Photopic Range Measurement: One of our key differentiators is our ability to measure vision within the photopic range, aligning perfectly with existing visual field platforms' standards. This ensures consistent clinical training and facilitates comparison to patients' prior examinations, ultimately enhancing outcomes. 🌟 4️⃣ Innovation in Action: RadiusXR is not just pushing boundaries but redefining them. This technology combines spatial computing with precision engineering to deliver unparalleled accuracy and reliability. From glaucoma staging to monitoring disease progression, RadiusXR is paving the way for a brighter future in ocular health. #RadiusXR #Innovation #OcularHealth #MedicalTechnology #VisionaryTech

Here is a link to my ARVO session info and abstract. I would love it if you'd stop by to chat! https://lnkd.in/ejZX-s9T

In the latest episode of Science@UH, Daniel Simon,MD, and renowned ophthalmologist Jonathan Lass, MD, explore groundbreaking innovations in eye care from pioneering reading centers to advances in corneal transplants and treatments for macular degeneration. Learn more about the future of ophthalmology and how clinical research is shaping new therapeutic solutions for eye diseases at https://bit.ly/3XBfZY2

One of the ways to stay ahead in ophthalmology clinical research is by keeping up with the latest NEI findings. At True North, we leverage this knowledge to design more effective trials. What recent eye research excites you? Share below. #eyeinnovation #clinicalresearch #contractresearchorganization  National Eye Institute (NEI)

Unlock Mondays with an exciting publication! Have you ever wondered about the pathways to geographic atrophy in non-neovascular age-related macular degeneration? Explore the insights from the publication 'Pathways to Geographic Atrophy in Non-Neovascular Age-Related Macular Degeneration.' This study provides a detailed characterization and quantification of precursor lesions of geographic atrophy (GA) in a retrospective analysis of eyes with age-related macular degeneration (AMD). How might these findings impact our understanding of AMD progression? Stay informed with the latest research in ophthalmology. Discover it! Here is the link: https://lnkd.in/dui7iYQZ #Ophthalmology #Publication #AMD #GeographicAtrophy #Research

👁💢 Breaking News: OCTA Predicts Faster Visual Field Loss! 💢👁 A new study from JAMA Ophthalmology reveals the power of Optical Coherence Tomography Angiography (OCTA) in predicting visual field progression in glaucoma patients! 🌟 https://bit.ly/4ag742P ⚠️ Rapid initial optic nerve head capillary density loss, as measured by OCTA, is linked to faster visual field MD loss and increased risk of event progression. 🔬 This groundbreaking research underscores the potential of OCTA in assessing glaucoma risk and guiding early interventions. 🚀 Credit: JAMA Ophthalmology #OCTA #Glaucoma #VisualHealth #MedicalScience #visualloss #meded #eMednews

LAST CALL: Urgent Extension for Abstract Submission! Time is running out! We're extending the abstract submission for OSWI's 35th Congress, but the window is closing FAST. You now have until January 14, 2024, @ midnight! This is YOUR moment to make a mark on the global ophthalmology stage. Don't let this opportunity slip away – submit your abstract NOW to be part of the most thrilling event in the field! Urgency is in the air! Act NOW and be a pivotal force in shaping the future of ophthalmology! The clock is ticking loudly! #OSWI35thCongress #LastCallAbstracts #OphthalmologyInnovation

🔬👁️ Dr. Baruch D. Kuppermann reflects on a pivotal shift in clinical research, triggered by recent changes in trial endpoints for dry AMD treatments. This 'sea change' opens up vast opportunities for innovation, encouraging companies beyond just Stealth BioTherapeutics to develop treatments that meet these new standards—potentially transforming care for one of ophthalmology's greatest unmet needs. Anticipate more durable, less frequent treatments as a result of this advancement. #Ophthalmology #ClinicalResearch #Innovation RIWC24: Retina International World Congress 2024

As we recognize #BrainAwarenessWeek, check out this interview with Shira Simon, MD, MBA, Director of Neuro-ophthalmology in the Dept. of Ophthalmology, as she discusses new research, clinical innovations, and what Northwestern Medicine is doing to elevate the Ophthalmology field.

🚀 #EURETINA24 Abstracts Now Available! 🚀 Dive into the latest research and discoveries in retinal care. Browse all Congress 2024 abstracts and stay ahead of the curve in ophthalmology. 🔍 Explore the abstracts here: https://ow.ly/W6OR50T2Pfo #RetinaResearch #Ophthalmology #MedicalInnovation #EURETINA24